Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2009 Feb;52(2):293–295. doi: 10.1002/pbc.21764

Fig. 1.

Fig. 1

Diffusion-weighted imaging (apparent diffusion coefficient map) of the brain at the onset of subacute methotrexate (MTX) neurotoxicity (A), resolution of the initial episode (B), recurrent neurotoxicity after rechallenge with intrathecal MTX (C) and resolution of recurrent episode (D). Areas of restricted diffusion are shown in arrows.